Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting on safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical effects of AMG 811 in subjects with psorias…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• AMG 811

Snippet

Sponsor: Amgen | Conditions: Psoriasis | Phase 1 | Status: COMPLETED